Total cases found were 14 with mean age 47.3±17 (male 64.3%). 10 cases (71.4%) had initial respiratory symptoms and 6 cases (42.8%) had fever. Common neurological manifestations included altered sensorium (92.8%), headache (42.8%), new onset seizure (35.7%), and dizziness (14.2%). Other features were behavioral issues, mutism, left sided paresis and paresthesia, ataxia, diplopia, bilateral facial weakness, hyposmia and ageusia. Six cases reported meningeal signs among which 71.4% had features of meningism. Out of twelve cases who had CSF analysis, four (33.3%) had normal findings, while the others had elevated CSF opening pressure and/or lymphocytic pleocytosis with elevated protein. Three cases had elevated CSF interleukin levels. SARS-CoV-2 was detected in the CSF of two cases. Eleven cases had MRI Brain imaging among which five cases were reported to have normal findings (45.5%), three cases had temporal lobe T2 hyperintensity (27.3%), one case had necrotizing hemorrhagic encephalitis, and one case had rhombencephalitis. Most of the patients were managed with empirical antibiotics, acyclovir, hydroxychloroquine, steroids, and anti-epileptics. Majority of the patients had complete and early recoveries with median time to recovery of 11 days (IQR 3-12.5). One case died with refractory seizure.